|
Volumn 111, Issue 2, 2003, Pages 441-443
|
Heliox questions [1] (multiple letters)
a a a b c d d e,f g |
Author keywords
[No Author keywords available]
|
Indexed keywords
HELIOX;
HELIUM;
INERT GAS;
OXYGEN;
ADRENALIN;
ARTERIOLE;
CHILD;
CLINICAL RESEARCH;
CROUP;
DRUG FORMULATION;
DRUG MECHANISM;
FLOW RATE;
GAS ANALYSIS;
HUMAN;
HYDROSTATIC PRESSURE;
LETTER;
LUNG ARTERIOVENOUS SHUNT;
LUNG CAPILLARY;
MEDICAL RESEARCH;
OXYGEN CONSUMPTION;
PRIORITY JOURNAL;
RACEMIC MIXTURE;
RISK ASSESSMENT;
STATISTICAL SIGNIFICANCE;
THERMAL CONDUCTIVITY;
TURBULENT FLOW;
VISCOSITY;
CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
ANOXIA;
ARTIFICIAL VENTILATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COMPARATIVE STUDY;
LUNG GAS EXCHANGE;
METHODOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
CHEMICALLY INDUCED DISORDER;
LESIONS AND DEFECTS;
PALLIATIVE THERAPY;
HELIUM;
NOBLE GASES;
OXYGEN;
ANOXIA;
EPINEPHRINE;
HUMANS;
LUNG DISEASES, OBSTRUCTIVE;
PULMONARY GAS EXCHANGE;
RESPIRATION, ARTIFICIAL;
DILATATION, PATHOLOGIC;
PALLIATIVE CARE;
|
EID: 0037313137
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: 10.1542/peds.111.2.441 Document Type: Letter |
Times cited : (12)
|
References (0)
|